Combined Positron Emission Tomography and Cerenkov Luminescence Imaging of Sentinel Lymph Nodes Using PEGylated Radionuclide-Embedded Gold Nanoparticles

Small ◽  
2016 ◽  
Vol 12 (35) ◽  
pp. 4894-4901 ◽  
Author(s):  
Sang Bong Lee ◽  
GhilSuk Yoon ◽  
Sang-Woo Lee ◽  
Shin Young Jeong ◽  
Byeong-Cheol Ahn ◽  
...  
Oncotarget ◽  
2016 ◽  
Vol 7 (41) ◽  
pp. 67403-67411 ◽  
Author(s):  
Florian C. Maier ◽  
Julia Schmitt ◽  
Andreas Maurer ◽  
Walter Ehrlichmann ◽  
Gerald Reischl ◽  
...  

2010 ◽  
Vol 21 (10) ◽  
pp. 1811-1819 ◽  
Author(s):  
Richard Ting ◽  
Todd A. Aguilera ◽  
Jessica L. Crisp ◽  
David J. Hall ◽  
William C. Eckelman ◽  
...  

2014 ◽  
Vol 21 (3) ◽  
pp. 159-161 ◽  
Author(s):  
Jacob Gelberg ◽  
Sean Grondin ◽  
Alain Tremblay

Staging of the mediastinal and hilar lymph nodes plays a crucial role in identifying the best treatment option for patients with confirmed or suspected lung cancer and, in many cases, can simultaneously confirm a diagnosis of cancer. Noninvasive modalities, such as computed tomography (CT), positron emission tomography (PET) and PET-CT, are an important first step in this assessment. Ultimately, invasive staging is frequently required to confirm or rule out the presence of metastatic disease within the lymph nodes. The present focused review describes and compares noninvasive and invasive modalities for mediastinal staging in lung cancer.


2015 ◽  
Vol 100 (1) ◽  
pp. 180-184 ◽  
Author(s):  
Hiroto Muroi ◽  
Masanobu Nakajima ◽  
Hitoshi Satomura ◽  
Masakazu Takahashi ◽  
Yasushi Domeki ◽  
...  

Abstract A 53-year-old man with multiple liver metastasis of esophageal cancer underwent four courses of chemotherapy. After four courses of chemotherapy, positron emission tomography showed progressive disease. Because it was difficult to control the cancer only by chemotherapy, we performed proton beam therapy (PBT) combined with chemotherapy. The irradiated parts were the primary tumor, liver metastases (S2/S4/S6), and mediastinal lymph nodes. The primary tumor including the mediastinal lymph nodes and the S2/S4/S6 metastases received proton beam irradiation at a total dose of 68.2 Gy in 31 fractions and 66.0 Gy in 30 fractions, respectively, according to tumor location. This resulted in a complete response as shown by positron emission tomography. In our experience, PBT exerted a curative effect on liver metastases of esophageal cancer. It is thought that PBT may be effective in the treatment of esophageal cancer. This is the first report about PBT for liver metastases of esophageal cancer.


Sign in / Sign up

Export Citation Format

Share Document